[PHARMA] QoQ Annualized Quarter Result on 30-Sep-2012 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
06-Nov-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Sep-2012 [#3]
Profit Trend
QoQ- 4.58%
YoY- 73.18%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 1,875,944 2,001,356 1,812,346 1,773,256 1,806,964 1,786,980 1,520,981 15.02%
PBT 93,058 147,696 103,313 132,088 141,146 171,820 73,186 17.38%
Tax -30,410 -47,084 -40,108 -37,856 -50,870 -55,576 -20,401 30.52%
NP 62,648 100,612 63,205 94,232 90,276 116,244 52,785 12.10%
-
NP to SH 61,272 99,084 61,710 92,860 88,796 114,740 52,157 11.34%
-
Tax Rate 32.68% 31.88% 38.82% 28.66% 36.04% 32.35% 27.88% -
Total Cost 1,813,296 1,900,744 1,749,141 1,679,024 1,716,688 1,670,736 1,468,196 15.12%
-
Net Worth 481,681 484,829 471,886 496,623 481,282 474,161 514,273 -4.27%
Dividend
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Div 35,323 35,303 41,187 39,227 35,301 35,297 35,304 0.03%
Div Payout % 57.65% 35.63% 66.74% 42.24% 39.76% 30.76% 67.69% -
Equity
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Net Worth 481,681 484,829 471,886 496,623 481,282 474,161 514,273 -4.27%
NOSH 258,968 117,676 117,677 117,683 117,672 117,657 117,682 69.26%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin 3.34% 5.03% 3.49% 5.31% 5.00% 6.51% 3.47% -
ROE 12.72% 20.44% 13.08% 18.70% 18.45% 24.20% 10.14% -
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
RPS 724.39 1,700.72 1,540.10 1,506.80 1,535.58 1,518.79 1,292.44 -32.04%
EPS 23.66 84.20 52.44 78.91 75.46 97.52 44.32 -34.21%
DPS 13.64 30.00 35.00 33.33 30.00 30.00 30.00 -40.90%
NAPS 1.86 4.12 4.01 4.22 4.09 4.03 4.37 -43.44%
Adjusted Per Share Value based on latest NOSH - 117,646
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
RPS 130.16 138.86 125.75 123.04 125.37 123.99 105.53 15.02%
EPS 4.25 6.87 4.28 6.44 6.16 7.96 3.62 11.30%
DPS 2.45 2.45 2.86 2.72 2.45 2.45 2.45 0.00%
NAPS 0.3342 0.3364 0.3274 0.3446 0.3339 0.329 0.3568 -4.27%
Price Multiplier on Financial Quarter End Date
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Date 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 -
Price 4.49 8.26 8.10 7.55 10.18 5.90 5.36 -
P/RPS 0.62 0.49 0.53 0.50 0.66 0.39 0.41 31.77%
P/EPS 18.98 9.81 15.45 9.57 13.49 6.05 12.09 35.11%
EY 5.27 10.19 6.47 10.45 7.41 16.53 8.27 -25.96%
DY 3.04 3.63 4.32 4.42 2.95 5.08 5.60 -33.47%
P/NAPS 2.41 2.00 2.02 1.79 2.49 1.46 1.23 56.64%
Price Multiplier on Announcement Date
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Date 16/08/13 15/05/13 18/02/13 06/11/12 08/08/12 03/05/12 22/02/12 -
Price 4.66 9.26 7.80 8.25 8.83 5.90 5.90 -
P/RPS 0.64 0.54 0.51 0.55 0.58 0.39 0.46 24.65%
P/EPS 19.70 11.00 14.87 10.46 11.70 6.05 13.31 29.90%
EY 5.08 9.09 6.72 9.56 8.55 16.53 7.51 -22.96%
DY 2.93 3.24 4.49 4.04 3.40 5.08 5.08 -30.73%
P/NAPS 2.51 2.25 1.95 1.95 2.16 1.46 1.35 51.26%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment